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Abstract 
Meningeal carcinomatosis occurs in 1–18% of patients with solid tumours, most 
commonly carcinomas of the breast and lung or melanomas. There are relatively few 
reports of meningeal carcinomatosis in transitional cell carcinoma of the bladder. 
Isolated meningeal recurrence is particularly uncommon, and we present an unusual 
case of this in a 58-year-old man. The case was further complicated by the somewhat 
atypical presentation with a confirmed ischaemic stroke. The patient died one month 
after presentation. 
 
Case Report 
A 58-year-old man was admitted with a 2-month history of headache and a 2-day history of ataxia. 
There was no photophobia or neck stiffness, but he had vomited occasionally. Physical examination was 
unremarkable other than ataxia affecting all 4 limbs. 
The patient had a previous history of a high-grade transitional cell cancer (TCC) of the bladder 
diagnosed earlier that year after presenting with dysuria, urinary frequency and renal failure with 
bilateral hydronephrosis. Bladder biopsies had revealed grade 3 muscle-invasive TCC of the bladder. 
The tumour was staged as T2 N1 M0 on CT imaging (with small pelvic nodes). The patient had 
completed 4 cycles of neoadjuvant chemotherapy with gemcitabine/cisplatin with good response and 
subsequently had pelvic radiotherapy (52.4 Gy in 20 fractions) completed 5 months prior to this most 
recent admission. A check cystoscopy 2 months after treatment showed no evidence of tumour 
recurrence. He had also had a previous pulmonary embolus and was receiving prophylactic low-
molecular-weight heparin. 
The patient underwent a CT brain scan, which showed a probable infarct in the left parietal lobe. He 
then developed an acute onset of left-sided weakness, left homonymous hemianopia, and left-sided  
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neglect in keeping with a right-sided total anterior circulation stroke. A repeat CT brain scan showed 
the previous lesion in the left parietal lobe, but also an early infarct affecting the caudate, the internal 
capsule and the lentiform nucleus on the right side (fig. 1). An MRI brain scan subsequently confirmed 
infarction in these areas, extending into the right posterior temporal and lower parietal regions (fig. 2). 
Carotid Doppler examination, Holter monitor, and transthoracic echocardiogram with agitated 
saline were all normal. The patient’s blood results showed a normal full blood count, urea and 
electrolytes, erythrocyte sedimentation rate, glucose and lipid levels. His liver function tests were 
abnormal with alkaline phosphatase 193 and gamma GT 117. An abdominal ultrasound scan was 
normal. 
The patient’s severe generalised headache persisted, and a lumbar puncture was performed. The 
sample was bloodstained, with red cells 11,097/μl and white cells 124/μl. Microbiological and virological 
investigations were negative. The cerebrospinal fluid (CSF) cytology showed malignant cells which were 
strongly positive for CK7 and CK20 on immunocytochemistry. This was the same immunostaining 
pattern as that of the original TCC of the bladder (fig. 3). 
A CT scan of the chest and abdomen showed some fat stranding around the bladder, but no solid 
tumour mass or lymphadenopathy was identified. Unfortunately, the patient’s general condition 
continued to deteriorate, and he was not fit for any further active treatment. He was treated 
symptomatically and died 1 month after his admission. 
Discussion 
Meningeal carcinomatosis (MC) occurs in 1–18% of patients with solid tumours, most 
commonly carcinomas of the breast and lung or melanomas [1–3]. Presenting 
neurological features depend on whether the cerebral hemispheres, cranial nerves, spinal 
cord or nerve roots are involved [4]. The most common presenting symptoms are 
headache (which occurs in up to 50% of cases), nausea and vomiting, limb weakness and 
radicular pain. The most frequent clinical features are cauda equina syndrome, 
polyradiculopathy, cranial nerve deficits and alteration in mental status [1]. Seizures 
occur in 20% of the cases, and stroke-like symptoms, cerebellar signs and encephalopathy 
have also been reported [1, 4, 5]. 
Contrast-enhanced MRI scanning is the most sensitive and specific imaging modality 
in the detection of MC but has an estimated sensitivity of 34–71%. False positives can be 
due to meningitis (this is particularly important if the patient is immunosuppressed), 
recent surgery or radiotherapy causing dilatation of the spinal arteries. Cerebral infarction 
may also mimic MC [4, 6]. 
A small number of reports of MC in TCC of the bladder exist in the literature. Ten 
cases have been reported in patients with more than one site of metastatic disease and 2 
cases with isolated meningeal recurrence. All cases demonstrated poor outcome, with a 
survival of 3–5 weeks following the diagnosis of MC [7]. It may be that the increasing use 
of neoadjuvant systemic chemotherapy for muscle-invasive bladder cancer will be 
associated with more frequent relapses with central nervous system disease, as has been 
the case, for example, with breast cancer. 
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Fig. 1. CT brain scan. 
 
 
 
Fig. 2. MRI brain scan. 
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Fig. 3. Cytology and immunocytochemistry (ICC) from the bladder and CSF. 
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